SPRC
BEARISHAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Ref P/E 0.00, P/B 0.03
- P/B ratio of 0.03 suggests assets are priced far below book value
- No earnings to support a P/E valuation
- Graham Number unavailable due to lack of earnings/book stability
Ref Growth metrics N/A
- Potential for binary biotech catalyst
- No revenue growth data provided
- Unsustainable burn rate implied by operating margins
Ref Historical price performance
- 1Y Change: -91.7%
- 5Y Change: -100%
- Price collapse from $94.50 to $4.42
Ref Piotroski F-Score, ROE
- Piotroski F-Score 3/9 (Weak)
- ROE of -1281.49%
- Operating Margin of -569.52%
Ref Dividend Yield N/A
- No dividend history
- 0% payout ratio
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for SPRC and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
SPRC
SciSparc Ltd.
Primary
|
-100.0% | -99.8% | -91.7% | -87.1% | -5.6% | +40.3% |
|
HCWB
HCW Biologics Inc.
Peer
|
-99.9% | -99.4% | -96.3% | -91.0% | -30.6% | +36.0% |
|
INM
InMed Pharmaceuticals Inc.
Peer
|
-100.0% | -97.1% | -71.7% | -66.3% | -10.5% | +5.6% |
|
PRFX
PRF Technologies Ltd.
Peer
|
-99.7% | -98.6% | -73.4% | -56.0% | +17.2% | +3.0% |
|
IMCC
IM Cannabis Corp.
Peer
|
-99.9% | -91.4% | -72.7% | -81.3% | -57.0% | +6.5% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q2 2025
Healthcare Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
SPRC
SciSparc Ltd.
|
BEARISH | $2.5M | 0.0 | -1281.5% | -% | $4.42 | |
|
HCWB
HCW Biologics Inc.
|
BEARISH | $2.45M | - | -% | -% | $0.36 | Compare |
|
INM
InMed Pharmaceuticals Inc.
|
BEARISH | $2.37M | - | -97.2% | -170.1% | $0.72 | Compare |
|
PRFX
PRF Technologies Ltd.
|
BEARISH | $2.31M | - | -90.4% | -% | $2.73 | Compare |
|
IMCC
IM Cannabis Corp.
|
BEARISH | $2.25M | - | -% | -20.7% | $0.36 | Compare |
SEC Filings
Recent regulatory filings from the SEC EDGAR database
Past News Coverage
Recent headlines mentioning SPRC from our newsroom.